semaglutide prediabetes weight loss diabetes prevention trial Efficacy and safety of once-weekly 2·4 mg versus placebo in people with obesity and (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 Updates in Medicine | CagriSema
Description
The Precision Peptide Genetic Test examines key variants that may provide context for your personalized cardiovascular response profile
Side Effects and Adverse Reactions VIII

This is because when youre on the medication, your appetite is so small that you may not take in enough calories

It is usually manageable